Based on published literature and extensive research that we conducted on symptomatic and asymptomatic patients and a variety of pulmonary upper tract diseases and infection, Breath of Health has been able to identify the specific COVID19 markers
Detection of SARS-CoV-2 infection by exhaled breath spectral analysis: Introducing a ready-to-use point-ofcare mass screening methodBreath of Health assuccessfully conducted clinical trials for COVID-19, which have been approved by the Israeli Ministry of Health at Shiba Tel and Hospitals.
The present application claims the benefits of priority of US ProvisionalBreath of Health assuccessfully conducted clinical trials for COVID-19, which have been approved by the Israeli Ministry of Health at Shiba Tel and Hospitals.
The present application claims the benefits of priority of US Provisional